Searching the Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
This study explored the clinical application of ventriculoperitoneal (VP) shunting in treating traumatic brain injury (TBI). A retrospective analysis was performed on 100 patients who had hydrocephalus due to TBI and were admitted to Shanxian Central Hospital from February 2012 to June 2016. Among these patients, 50 underwent VP shunting surgery and were assigned to the experimental group. The remaining 50 underwent lumboperitoneal (LP) shunting surgery and were assigned to the control group. Twenty days after surgery, all patients were evaluated for clinical outcomes, neurological deficit scores and complications. The results were compared between the two groups. Patients in the experimental group were further separated into three subgroups according to the severity of hydrocephalus, and clinical outcomes were compared among the subgroups. It was found that the effective rate in the experimental group was significantly higher than that in the control group, and the difference was statistically significant (P<0.05). The effective rate in the mild hydrocephalus subgroup was significantly higher than that in the severe hydrocephalus subgroup, with a statistically significant difference (P<0.05). The effective rate in the moderate hydrocephalus subgroup was significantly higher than that in the severe hydrocephalus subgroup, with a statistically significant difference (P<0.05). The incidence of complications in the control group was significantly higher than that in the experimental group, and the difference was statistically significant (P<0.05). The postoperative neurological deficit score in the experimental group was significantly lower than that in the control group, and the difference was statistically significant (P<0.05). In conclusion, patients with hydrocephalus due to TBI had better clinical outcome when treated with VP shunting than those treated with LP shunting. Moreover, a better outcome was observed when the patient had milder hydrocephalus. Therefore, the early diagnosis and timely treatment with VP shunting are of great importance for patients with hydrocephalus.
Pubmed ID: 31572501
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Medical technology company that develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders, and diabetes. A Commercial healthcare organization for both patients and healthcare professionals. For professionals, it provides products, therapy and procedure solutions, and services.
View all literature mentions